Wikidata

(Q63062120)

English

A Placebo Controlled 4 Week Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild Atopic Dermatitis (RO-2351-001-EM)

clinical trial

In more languages

Statements

title
A Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild Atopic Dermatitis (English)
0 references
medical condition
dermatitis
0 references
eczema
0 references
sponsor
AstraZeneca
0 references
start time
November 2008
0 references
end time
June 2009
0 references
number of participants
0
0 references
minimum age
18 year
0 references
maximum age
65 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63062120&oldid=1857093215"